Efficacy and safety associated with immune checkpoint inhibitors in unresectable hepatocellular carcinoma: A re-analysis of a meta-analysis

被引：0
|
作者：
Zhou, Shouhao [1 ,2 ,4 ]
Shen, Chan [1 ,2 ,3 ]
机构：
[1] Penn State Univ, Coll Med, Dept Publ Hlth Sci, Hershey, PA 17033 USA
[2] Penn State Univ, Penn State Canc Inst, Hershey, PA 17033 USA
[3] Penn State Univ, Coll Med, Dept Surg, Hershey, PA 17033 USA
[4] Penn State Univ, Dept Publ Hlth Sci, 90 Hope Dr,ASB 3400L, Hershey, PA 17033 USA
来源：
JGH OPEN | 2023年 / 7卷 / 02期
关键词：
Bayesian statistics; immune checkpoint inhibitors; meta-analysis; predictive intervals; unresectable hepatocellular carcinoma;
D O I：
10.1002/jgh3.12856
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
We identified analytic limitations in a recent meta-analysis and re-examined the efficacy and safety associated with immune checkpoint inhibitors (ICIs) in unresectable hepatocellular carcinoma (HCC) compared with standard therapies. Our findings mostly contradict conclusions from the previous study, suggesting the need for continuing the investigation of ICIs in HCC with additional clinical evidence.
引用
收藏
页码：163 / 164
页数：2
相关论文
共 50 条
  • [21] Efficacy and safety of immune checkpoint inhibitors in the treatment of recurrent or metastatic nasopharyngeal carcinoma: A systematic review and meta-analysis
    Yu Zhixin
    Hong Shaodong
    Yu Hui
    Zhang Xuanye
    Li Zichun
    Chen Ping
    Zhou Yixin
    中华医学杂志英文版, 2025, 138 (05)
  • [22] Efficacy and safety of TACE combined with tyrosine kinase inhibitors and camrelizumab for unresectable hepatocellular carcinoma: A systematic review and meta-analysis
    Yu, Jiahui
    Yan, Duan
    Wei, Song
    Yang, Linfeng
    Yi, Pengsheng
    ONCOLOGY LETTERS, 2024, 28 (02)
  • [23] The efficacy of immune checkpoint inhibitors in advanced hepatocellular carcinoma: a meta-analysis based on 40 cohorts incorporating 3697 individuals
    Wang, Rixiong
    Lin, Nan
    Mao, Binbin
    Wu, Qing
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2022, 148 (05) : 1195 - 1210
  • [24] The efficacy of immune checkpoint inhibitors in advanced hepatocellular carcinoma: a meta-analysis based on 40 cohorts incorporating 3697 individuals
    Rixiong Wang
    Nan Lin
    Binbin Mao
    Qing Wu
    Journal of Cancer Research and Clinical Oncology, 2022, 148 : 1195 - 1210
  • [25] Efficacy and safety of hepatic arterial infusion chemotherapy combined with immune checkpoint inhibitors and tyrosine kinase inhibitors in advanced hepatocellular carcinoma: A systematic review and meta-analysis
    Li, Zixiong
    Xu, Yanping
    Qu, Wenshu
    Liu, Ping
    Zhu, Yan
    Li, Hui
    Guo, Ying
    Liu, Xiufeng
    ONCOLOGY LETTERS, 2023, 26 (06)
  • [26] Efficacy and safety of immune checkpoint inhibitors-combined antiangiogenic drugs in the treatment of hepatocellular carcinoma: A systematic review and meta analysis
    Zhong, Yu
    Huo, Hong
    Dai, Shuqi
    Li, Su
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [27] Cost effectiveness of immune checkpoint inhibitors for treatment of Hepatocellular Carcinoma: A systematic review and Meta-analysis
    Dawood, Zaiba Shafik
    Brown, Zachary J.
    Endo, Yutaka
    Katayama, Erryk S.
    Munir, Muhammad Musaab
    Alaimo, Laura
    Ruff, Samantha M.
    Lima, Henrique A.
    Woldesenbet, Selamawit
    Pawlik, Timothy M.
    SURGICAL ONCOLOGY-OXFORD, 2023, 51
  • [28] Efficacy and safety of immune checkpoint inhibitors for hepatocellular carcinoma patients with macrovascular invasion or extrahepatic spread: a systematic review and meta-analysis of 54 studies with 6187 hepatocellular carcinoma patients
    Han, Cheng-Long
    Tian, Bao-Wen
    Yan, Lun-Jie
    Ding, Zi-Niu
    Liu, Hui
    Mao, Xin-Cheng
    Tian, Jin-Cheng
    Xue, Jun-Shuai
    Tan, Si-Yu
    Dong, Zhao-Ru
    Yan, Yu-Chuan
    Hong, Jian-Guo
    Chen, Zhi-Qiang
    Wang, Dong-Xu
    Li, Tao
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2023, 72 (07) : 1957 - 1969
  • [29] Efficacy and safety of immune checkpoint inhibitors for hepatocellular carcinoma patients with macrovascular invasion or extrahepatic spread: a systematic review and meta-analysis of 54 studies with 6187 hepatocellular carcinoma patients
    Cheng-Long Han
    Bao-Wen Tian
    Lun-Jie Yan
    Zi-Niu Ding
    Hui Liu
    Xin-Cheng Mao
    Jin-Cheng Tian
    Jun-Shuai Xue
    Si-Yu Tan
    Zhao-Ru Dong
    Yu-Chuan Yan
    Jian-Guo Hong
    Zhi-Qiang Chen
    Dong-Xu Wang
    Tao Li
    Cancer Immunology, Immunotherapy, 2023, 72 : 1957 - 1969
  • [30] Potential predictors for survival in hepatocellular carcinoma patients treated with immune checkpoint inhibitors: A meta-analysis
    Xu, Huilin
    Cao, Dedong
    Zheng, Yongfa
    Zhou, Dingjie
    Chen, Xin
    Lei, Jinju
    Ge, Wei
    Xu, Ximing
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2021, 100
12345